Neurelis
Specialty pharmaceutical firm that licenses, develops, and commercializes product candidates for epilepsy and the cns market. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
AUD705m—1.1b (Dealroom.co estimates Mar 2021.)
San Diego California (HQ)
Authorizing premium user...